ArticleAnnals of global health2021
Corporate Response Against COVID-19: Manufacturing Shift by Ford-Otosan.
Article in Annals of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the time of disasters and crisis, governmental organizations are responsible for performing disaster-relief tasks and providing economic support. However, these organizations may fail to fulfill their duties in emerging and developing market settings either because of a lack of resources or bureaucratic inefficiencies. At the rise of these situations, corporations are expected to help society via corporate social responsibility (CSR) projects. This viewpoint article reflects upon the Ford-Otosan's attempt to devise a CSR project to support Turkish citizens during the COVID-19 crisis and meet the public's expectations. This study aims to set a future research agenda on CSR and multinational joint-ventures' non-market strategies by illustrating a unique insight into an international joint-venture during the COVID-19 crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.